Pharma supply chains

Lonza sells off its capsules division to British firm

This content was published on Mar 7, 2026 The Swiss firm is selling its capsules and health ingredients business to Lone Star Funds for CHF2.3 billion ($3 billion).

The banking sector has been particularly affected by redundancies.

Pharma supply chains

Why unemployment in Switzerland is increasing more than elsewhere in Europe

This content was published on Feb 24, 2026 The number of people in Switzerland who are out of work increased for the second year in a row. This contrasts with the situation in the European Union.

Healthcare innovation

Swiss pharma’s global success meets worries at home

This content was published on Feb 13, 2026 Switzerland’s two biggest pharmaceutical companies are doing well. Why is the country so worried?

Novartis: new global biomedical research centre opens in San Diego

Pharma supply chains

Novartis begins construction of new research centre in San Diego, US

This content was published on Feb 9, 2026 Novartis has begun work on a new global biomedical research centre in San Diego, United States. The 43,300 m2 facility will be operational in 2029 and house around 1,000 employees.

Medicines: sales increase by 5% in Switzerland in 2025

Drug pricing

Swiss medicine revenues pegged back by price reductions

This content was published on Feb 7, 2026 Swiss pharma market records CHF8.1 billion revenues at factory prices in 2025.

Healthcare innovation

Going global: Weleda’s new CEO wants to put the cosmetics company on the map

This content was published on Jan 31, 2026 Weleda CEO Tina Müller talks about the quiet revolution she initiated at the Swiss cosmetics and healthcare company.

Roche achieves research success with novel fat-lowering agent

New treatments

Roche reports positive results for experimental obesity drug

This content was published on Jan 27, 2026 Roche says that a phase II clinical trial of its experimental obesity drug CT-388 has given positive results.

Pharma supply chains

Vaccine maker Janssen closes plant in Bern

This content was published on Dec 31, 2025 Janssen to close Bern vaccine plant by 2026, with job cuts and a planned site sale.

Economic sentiment continues to brighten according to KOF Barometer

Workplace

Swiss economic sentiment continues to improve according to KOF barometer

This content was published on Dec 30, 2025 Swiss economic sentiment rises for a fourth month, driven by gains in manufacturing.

Healthcare innovation

US trade deal forces reckoning for Swiss pharma powerhouse

This content was published on Nov 18, 2025 Swiss pharma made massive investment promises to the US that are fueling anxiety about the industry's future in Switzerland.

Pharma supply chains

Popular Stories

Most Discussed

Pharma supply chains

More

Lonza sells off its capsules division to British firm

More

Why unemployment in Switzerland is increasing more than elsewhere in Europe

More

Swiss pharma’s global success meets worries at home

More

Novartis begins construction of new research centre in San Diego, US

More

Swiss medicine revenues pegged back by price reductions

More

Going global: Weleda’s new CEO wants to put the cosmetics company on the map

More

Roche reports positive results for experimental obesity drug

More

Vaccine maker Janssen closes plant in Bern

More

Swiss economic sentiment continues to improve according to KOF barometer

More

US trade deal forces reckoning for Swiss pharma powerhouse

Popular Stories

Most Discussed